Amgen's Adcomm Meeting Paves Way To Launch Boost For Mirati Therapeutics' Lung Cancer Drug: Analysts
Benzinga
OCTOBER 6, 2023
According to a report on Thursday, French pharma company Sanofi SA (NASDAQ: SNY ) is reportedly exploring a potential acquisition of cancer drugmaker Mirati Therapeutics Inc (NASDAQ: MRTX ). Sanofi's backing would also help Mirati commercialize Krazati and fund treatment and further studies, Bloomberg noted.
Let's personalize your content